"Corporate profile" An English version and a Japanese version are updated.
Sumitomo Dainippon Pharma Announces Transfer of Certain Fixed Assets
Latuda (lurasidone), a New Atypical Antipsychotic Agent for Adults with Schizophrenia, Now Available in the UK, Offers a Combination of Efficacy with Tolerability
Posted Conference Call for First Quarter Financial Results for FY2014 [Webcast]
Presentation Material (First Quarter Financial Results for FY2014)
Supplementary Financial Data for the First Quarter of the Year Ending March 31, 2015
A Message from the President
Board of Directors and Executive Officers